Wellington Management Group LLP Lowers Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wellington Management Group LLP reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,512 shares of the exchange traded fund’s stock after selling 500 shares during the period. Wellington Management Group LLP’s holdings in SPDR S&P Biotech ETF were worth $2,301,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Verity Asset Management Inc. raised its stake in SPDR S&P Biotech ETF by 7.9% during the 3rd quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock valued at $1,258,000 after purchasing an additional 1,266 shares during the period. Sowell Financial Services LLC raised its stake in SPDR S&P Biotech ETF by 53.3% during the 2nd quarter. Sowell Financial Services LLC now owns 18,249 shares of the exchange traded fund’s stock valued at $1,518,000 after purchasing an additional 6,346 shares during the period. Thrivent Financial for Lutherans raised its stake in SPDR S&P Biotech ETF by 557.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 236,081 shares of the exchange traded fund’s stock valued at $19,642,000 after purchasing an additional 200,178 shares during the period. Cerity Partners LLC raised its stake in SPDR S&P Biotech ETF by 663.8% during the 2nd quarter. Cerity Partners LLC now owns 83,610 shares of the exchange traded fund’s stock valued at $6,956,000 after purchasing an additional 72,664 shares during the period. Finally, EP Wealth Advisors LLC raised its stake in SPDR S&P Biotech ETF by 132.1% during the 3rd quarter. EP Wealth Advisors LLC now owns 20,786 shares of the exchange traded fund’s stock valued at $1,518,000 after purchasing an additional 11,832 shares during the period.

SPDR S&P Biotech ETF Trading Up 2.4 %

Shares of XBI opened at $94.91 on Thursday. The business’s 50 day moving average is $93.27 and its 200 day moving average is $82.57. The company has a market capitalization of $7.28 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.